EP Patent

EP0299527A1 — Doxorubicin hydrochloride aqueous solutions

Assigned to Bristol Myers Squibb Co · Expires 1989-01-18 · 37y expired

What this patent protects

Stable ready-to-use aqueous solutions of doxorubicin HCl are provided containing doxorubicin HCl, citric acid, an antioxidant selected from α-tocopherol (Vitamin E), sodium formaldehyde bisulfite and tert-butylhydroquinone, and water. The solutions have an acceptable shelf-life o…

USPTO Abstract

Stable ready-to-use aqueous solutions of doxorubicin HCl are provided containing doxorubicin HCl, citric acid, an antioxidant selected from α-tocopherol (Vitamin E), sodium formaldehyde bisulfite and tert-butylhydroquinone, and water. The solutions have an acceptable shelf-life of greater than two years at 4°C.

Drugs covered by this patent

Patent Metadata

Patent number
EP0299527A1
Jurisdiction
EP
Classification
—
Expires
1989-01-18
Drug substance claim
No
Drug product claim
No
Assignee
Bristol Myers Squibb Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.